Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi
- 9 December 2016
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 30 (3) , 350-356
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- High Throughput Mass Spectrometry-Based Mutation Profiling of Primary Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2012
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- Kinetic Scaffolding Mediated by a Phospholipase C–β and G q Signaling ComplexScience, 2010
- State of the Art, Nomenclature, and Points of Consensus and Controversy Concerning Benign Melanocytic Lesions: Outcome of an International WorkshopAdvances in Anatomic Pathology, 2010
- Blue Nevi and Related LesionsAdvances in Anatomic Pathology, 2009
- So‐called “malignant blue nevus”Cancer, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Congenital Melanocytic Nevi Frequently Harbor NRAS Mutations but no BRAF MutationsJournal of Investigative Dermatology, 2007
- Dermal dendritic melanocytic proliferations: an updateHistopathology, 2004